AI Science Tracker
EN

Brain tumor IDH, 1p/19q, and MGMT molecular classification using MRI-based deep learning: an initial study on the effect of motion and motion correction.

Affiliation not stated in the reviewed material · 27 Jan 2022 · medicine

Discovery

Brain tumor IDH, 1p/19q, and MGMT molecular classification using MRI-based deep learning: an initial study on the effect of motion and motion correction.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: MRI-based deep learning predicts glioma IDH, 1p/19q, and MGMT molecular status and measures the effect of motion and motion correction on those predictions.

Technology: The source compares molecular-classification performance across motion conditions in a brain-tumor imaging cohort.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The source compares molecular-classification performance across motion conditions in a brain-tumor imaging cohort.
Limitation / still unknown
The MRI molecular-status result is limited to the reported cohort and acquisition conditions; no external clinical validation is stated.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/35118164 · https://pmc.ncbi.nlm.nih.gov/articles/PMC8794036/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.